PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
PTC Therapeutics (NASDAQ: PTCT) will report fourth quarter and full year 2025 financial results on Thursday, Feb. 19, 2026 at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) will report fourth quarter and full year 2025 financial results on Thursday, Feb. 19, 2026 at 4:30 p.m. ET. The company will host a webcast conference call to discuss results, business updates, and outlook.
Investors can register for phone access or join the webcast on the company's Investors site. A replay will be archived on the company website for 30 days.
Details
News Market Reaction – PTCT
On Feb 5, the day this news came out, PTCT closed 2.10% below the previous close.
Data tracked by StockTitan Argus for the Feb 5 session.
Key Figures
- Earnings call date
- Feb. 19, 2026
- Fourth quarter and full year 2025 results
- Earnings call time
- 4:30 p.m. ET
- Start time of webcast conference call
- Replay duration
- 30 days
- Webcast replay archived on company website
Historical Context
-
Preliminary 2025 revenue and detailed 2026 guidance with Sephience contribution.
-
Small RSU inducement grant under Nasdaq Listing Rule 5635(c)(4).
-
Japanese approval for Sephience for PKU across all ages and severities.
-
Stock options and RSUs granted to new employees under Nasdaq inducement rules.
-
Announcement of J.P. Morgan Healthcare Conference presentation and webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the call by phone, please click here to register and you will be provided with dial-in details. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be archived on the company's website for 30 days.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on LinkedIn, X, Facebook, and Instagram.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-thursday-feb-19-2026-302679246.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.